# Emtricitabine and tenofovir disoproxil fumarate

NDC: 67296-2198
Generic name: Emtricitabine and tenofovir disoproxil fumarate
Labeler / Manufacturer: Redpharm Drug
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20211007

FDA application: ANDA201806

## Active ingredients

- EMTRICITABINE: 200 mg/1
- TENOFOVIR DISOPROXIL FUMARATE: 300 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"67296-2198"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=67296-2198
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=44f2503d-7863-61a8-e063-6394a90a83c4